drugset / Trial / NCT00110773

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults

NCT00110773

Phase 3 Completed 80 enrolled ZARS Pharma Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Pulsed dye laser (PDL) on the face is painful. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate the efficacy of S-Caine Peel for induction of local dermal anesthesia for PDL therapy in adults.

Timeline

Start
2005-06
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 7 % Topical
Subject tetracaine Other / unclassified 7 % Topical

Indications

No indication recorded.